Can you stay on 2.5mg of Mounjaro, or do you have to go higher?

The myth: 2.5mg is too low to do anything, so why not skip straight past it?

This is probably the question your prescriber has heard before. The assumption is that 2.5mg is basically a placeholder, so staying on it feels pointless. That's not quite right. The starter dose isn't inert, it still activates the same dual GIP and GLP-1 receptors that drive the medicine's effect on appetite and gastric emptying. What it isn't is the dose at which most people see the weight loss shown in the clinical trials. Its job, primarily, is to reduce the nausea, vomiting and digestive disruption that comes when you start a GLP-1-based medicine. It's an adjustment period, not a therapeutic plateau for most patients.

That said, some people do notice appetite changes even at 2.5mg. Others find the first few weeks uncomfortable enough that holding at this level a little longer is genuinely sensible. The point is: the 2.5mg dose is doing something, and dismissing it entirely misses why the titration schedule exists in the first place. The NHS medicines page for tirzepatide confirms that 2.5mg is the standard starting dose, with increases typically at four-weekly intervals as directed by your prescriber.

If you're curious about how lower doses compare more broadly, our guide to staying on a low dose of Mounjaro covers the wider picture.

When staying on 2.5mg might actually be the right call

There are legitimate clinical situations in which a prescriber might pause titration at 2.5mg for longer than four weeks, or even hold someone there indefinitely. Side effects are the most common reason. If nausea, vomiting or diarrhoea are significant, it makes no clinical sense to push to a higher dose before the current one is tolerated properly. Rushing the titration tends to worsen GI side effects rather than accelerate results.

Other factors can come into play too: a recent illness, a planned surgical procedure (you'd need to discuss Mounjaro with your anaesthetist and healthcare team), or a period where the prescriber wants to monitor how you're responding before moving on. These aren't failures of the medicine, they're exactly the kind of individual clinical decisions that a prescriber is there to make.

What a prescriber won't do is keep you at 2.5mg indefinitely without a reason. If you're tolerating it well and your weight isn't responding, the evidence base (including SURMOUNT-1, which showed the largest average reductions at the higher doses) supports moving up. The 5mg Mounjaro dose is typically where most people begin to see more meaningful change, and some people do choose to stay at 5mg rather than going further.

Side effects at the starter dose are worth knowing about. Our page on Mounjaro dose clicks and side effects goes into more detail about what's typical as you adjust.

What your prescriber considers before any dose decision

Prescribers looking at dose management weigh a few things together. Tolerability is the first filter: are you managing the side effects at your current dose? Progress is the second: has there been meaningful weight loss over the expected period? And clinical context is the third: is there anything else going on that would make increasing less safe right now?

This is why trying to manage doses independently (staying low to avoid side effects, or increasing quickly to speed results) is the part that tends to go wrong. The titration schedule in Mounjaro's SmPC exists because the clinical evidence, gathered across thousands of adults in the SURMOUNT programme, showed that gradual escalation produces better tolerability without sacrificing long-term outcomes.

It's also worth understanding what the cost picture looks like across the titration journey. Our overview of Mounjaro pricing in the UK explains how private prescription costs typically vary by dose and what to watch for when comparing providers. For the full picture on how Mounjaro works and what the wider evidence shows, the Mounjaro treatment page is a good starting point.

If you're weighing whether a higher dose is right for you, our prescribers are the right people to ask. You can check your eligibility and get a same-day clinical review through our free consultation, a real prescriber reads your answers, not a queue for a bot. There's no obligation, and no fee for the consultation itself.